Patents by Inventor Rakesh Datta

Rakesh Datta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200360483
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hGhrelin.
    Type: Application
    Filed: February 3, 2020
    Publication date: November 19, 2020
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Zheng Xin DONG, John E. Taylor, Rakesh Datta, Michael DeWitt Culler
  • Publication number: 20200347110
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: December 20, 2019
    Publication date: November 5, 2020
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Publication number: 20190248861
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: October 24, 2018
    Publication date: August 15, 2019
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Publication number: 20170304403
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hGhrelin.
    Type: Application
    Filed: June 29, 2017
    Publication date: October 26, 2017
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Zheng Xin DONG, John E. TAYLOR, Rakesh DATTA, Michael DeWitt CULLER
  • Publication number: 20170037104
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: October 25, 2016
    Publication date: February 9, 2017
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Rakesh DATTA, Zheng Xin DONG
  • Patent number: 9499599
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Grant
    Filed: February 23, 2015
    Date of Patent: November 22, 2016
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Publication number: 20160206700
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hGhrelin.
    Type: Application
    Filed: January 18, 2016
    Publication date: July 21, 2016
    Applicant: Ipsen Pharma S.A.S.
    Inventors: Zheng Xin Dong, John E. Taylor, Rakesh Datta, Michael DeWitt Culler
  • Publication number: 20150218245
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: February 23, 2015
    Publication date: August 6, 2015
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Rakesh DATTA, Zheng Xin DONG
  • Publication number: 20150111823
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hGhrelin.
    Type: Application
    Filed: October 27, 2014
    Publication date: April 23, 2015
    Applicant: IPSEN PHARMA S.A.S.
    Inventors: Zheng Xin Dong, John E Taylor, Rakesh Datta, Michael DeWitt Culler
  • Patent number: 8981054
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: March 17, 2015
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Patent number: 8871706
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogous of native hGhrelin.
    Type: Grant
    Filed: August 7, 2008
    Date of Patent: October 28, 2014
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Zheng Xin Dong, Michael DeWitt Culler, Rakesh Datta, John E. Taylor
  • Publication number: 20110166069
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: March 11, 2011
    Publication date: July 7, 2011
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Publication number: 20110160133
    Abstract: The present invention provides a method of ameliorating inflammation, inhibiting proinflammatory cytokine and/or chemokine expression and treating various diseases and/or conditions incidental to the onset of inflammation, in a subject in need of treatment for such conditions, by administering select analogues of native hGhrelin.
    Type: Application
    Filed: August 7, 2008
    Publication date: June 30, 2011
    Inventors: Zheng Xin Dong, Michael Dewitt Culler, Rakesh Datta, Jonh E. Taylor
  • Patent number: 7932231
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Grant
    Filed: September 28, 2006
    Date of Patent: April 26, 2011
    Assignee: IPSEN Pharma, S.A.S.
    Inventors: Rakesh Datta, Zheng Xin Dong
  • Publication number: 20090304724
    Abstract: The present invention relates to a method of treating a transient impairment of the motility of the gastrointestinal system resulting from postoperative ileus in a patient wherein said method includes the step of administering a therapeutically effective amount of a peptidyl analog of ghrelin to said patient.
    Type: Application
    Filed: September 28, 2006
    Publication date: December 10, 2009
    Inventors: Rakesh Datta, Zheng Xin Dong